✦ LIBER ✦

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Scribed by Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; James Bolognese; Elliot Ehrich; Suarabh Mukhopadhyay; Brian Daniels

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 105 KB
Volume: 43
Category: Article
ISSN: 0004-3591
DOI: 10.1002/1529-0131(200005)43:5<978::aid-anr4>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, crossover cl

A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee

✍ T. Pincus; G. G. Koch; T. Sokka; J. Lefkowith; F. Wolfe; J. M. Jordan; G. Luta; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Effectiveness of behavioral graded activ

Effectiveness of behavioral graded activity in patients with osteoarthritis of the hip and/or knee: A randomized clinical trial

✍ Veenhof, Cindy ;Köke, Albère J. A. ;Dekker, Joost ;Oostendorp, Rob A. ;Bijlsma, 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## Objective To determine the effectiveness of a behavioral graded activity program (BGA) compared with usual care (UC; exercise therapy and advice) according to the Dutch guidelines for physiotherapy in patients with osteoarthritis (OA) of the hip and/or knee. The BGA intervention is

Comparing the efficacy of cyclooxygenase

Comparing the efficacy of cyclooxygenase 2–specific inhibitors in treating osteoarthritis: Appropriate trial design considerations and results of a randomized, placebo-controlled trial

✍ Allan Gibofsky; Gary W. Williams; Frank McKenna; John G. Fort 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

Effectiveness of exercise therapy in pat

Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: A systematic review of randomized clinical trials

✍ Margriet E. Van Baar; Willem J. J. Assendelft; Joost Dekker; Rob A. B. Oostendor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Comparison of the effect of rofecoxib (a

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

✍ Christopher Hawkey; Loren Laine; Thomas Simon; Andre Beaulieu; Jose Maldonado-Co 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m